Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis "ATTEST2"


Phase 3 Results N/A

Summary of Purpose

The principle research question is: in patients with acute ischaemic stroke eligible for intravenous (IV) thrombolysis, is tenecteplase superior in efficacy to alteplase, based on functional outcome as assessed by modified Rankin Scale distribution at day 90?

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 March 2018.

15 Dec 2016 23 Jun 2016 1 Aug 2019 1 Aug 2019 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Parallel Assignment